Status:
COMPLETED
Photodynamic Therapy With Verteporfin for Corneal Neovascularization
Lead Sponsor:
Chonnam National University Hospital
Conditions:
Corneal Neovascularization
Eligibility:
All Genders
35-70 years
Phase:
NA
Brief Summary
Purpose: To investigate the efficacy of photodynamic therapy with verteporfin for the treatment of patients with corneal neovascularization. Design: Prospective, non-comparative case series. Particip...
Eligibility Criteria
Inclusion
- Patients with clinically stable corneal neovascularization who were not improved after treatment with 1% prednisolone acetate eyedrops instilled 4 times a day for at least 1 month
Exclusion
- Individuals who had active keratitis with vessel proliferation, uncontrolled inflammation, active hepatitis or clinically significant liver disease, or porphyria or other porphyrin sensitivity
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00471406
Last Update
October 17 2008
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.